Methyl 6-bromo-5-oxo-4,5-dihydropyrazine-2-carboxylate

Catalog No. :
ACAMBQ510
CAS No. :
1017603-85-8
Molecular Formula :
C6H5BrN2O3
Molecular Weight :
233.02

IUPAC Name:methyl 6-bromo-5-oxo-4,5-dihydropyrazine-2-carboxylate

Methyl 6-bromo-5-oxo-4,5-dihydropyrazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$277.00Login to see priceIn stockIn stock
250mg97%$442.00Login to see priceIn stockIn stock
500mg97%$736.00Login to see priceIn stockInquiry
1g97%$1103.00Login to see priceIn stockIn stock
5g97%$2072.00Login to see priceInquiryInquiry
10g97%$3524.00Login to see priceInquiryInquiry
25g97%$7047.00Login to see priceInquiryInquiry
50g97%$11275.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 6-bromo-5-oxo-4,5-dihydropyrazine-2-carboxylate
IUPAC Namemethyl 6-bromo-5-oxo-4,5-dihydropyrazine-2-carboxylate
MDL No.MFCD31807405
Molecular FormulaC6H5BrN2O3
Molecular Weight233.02
SMILESO=C(C(N=C1Br)=CNC1=O)OC
InChI KeyIHBJNSCXVJDJST-UHFFFAOYSA-N
Synonymmethyl 6-bromo-5-hydroxypyrazine-2-carboxylate;methyl 5-bromo-6-oxo-1H-pyrazine-3-carboxylate
CAS No.1017603-85-8
PubChem CID59254840

Synthetic Route by SureRoute

1. ACAMBQ510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBAPG715 route compound structure diagram
    ACBAPG71513924-95-3 In Stock
  4. Then
  5. ACAMBQ510 route product structure diagram
    ACAMBQ5101017603-85-8 In Stock
Inquiry

2. ACAMBQ510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBAPG715 route compound structure diagram
    ACBAPG71513924-95-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAMBQ510 route product structure diagram
    ACAMBQ5101017603-85-8 In Stock
Inquiry

Comments (0)